Scope of the Report: The worldwide market for Cardiac Biomarker is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Cardiac Biomarker in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Alere Roche Diagnostics BG Medicine Biomerieux Critical Diagnostics DiaDexus Response Biomedical Siemens Healthcare Singulex Thermo Scientific Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Creatine kinase (CK) MB Troponin (cTnI and cTnT) BNP & NT-proBNP Myogloblin Others (hs-CRP, D-Dimer, etc.) Market Segment by Applications, can be divided into Myocardial Infarction Congestive Heart Failure Acute Coronary Syndrome Atherosclerosis Others The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Cardiac Biomarker product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of Cardiac Biomarker, with price, sales, revenue and global market share of Cardiac Biomarker in 2017 and 2018. Chapter 3, the Cardiac Biomarker competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Cardiac Biomarker breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019. Chapter 12, Cardiac Biomarker market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. Chapter 13, 14 and 15, to describe Cardiac Biomarker sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents 1 Market Overview 1.1 Cardiac Biomarker Introduction 1.2 Market Analysis by Type 1.2.1 Creatine kinase (CK) MB 1.2.2 Troponin (cTnI and cTnT) 1.2.3 BNP & NT-proBNP 1.2.4 Myogloblin 1.2.5 Others (hs-CRP, D-Dimer, etc.) 1.3 Market Analysis by Applications 1.3.1 Myocardial Infarction 1.3.2 Congestive He
